Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Other 2Gastrointestinal 2Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1Breast 1

Conditions

Urogenital Neoplasms 1Sarcoma 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sildenafil Citrate × Breast × Clear all
NCT01375699 2019-08-26

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Virginia Commonwealth University

Phase 1 Completed
26 enrolled
BreastGastrointestinalSarcoma

Breast Neoplasms, Gastrointestinal Neoplasms, Sarcoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡